Stockscreener 앱 받기
44.91
0.02%
-0.04
전일 마감가:
$44.87
열려 있는:
$44.47
하루 거래량:
418.40K
Relative Volume:
0.39
시가총액:
$3.36B
수익:
-
순이익/손실:
$-237.22M
주가수익비율:
-11.88
EPS:
-3.78
순현금흐름:
$-212.64M
1주 성능:
+6.38%
1개월 성능:
+22.13%
6개월 성능:
+37.02%
1년 성능:
+128.18%
1일 변동 폭
$43.71
$45.24
1주일 범위
$41.34
$46.47
52주 변동 폭
$17.86
$58.40
Akero Therapeutics Inc Stock (AKRO) Company Profile
명칭
Akero Therapeutics Inc
전화
650-487-6488
주소
601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO, CA
AKRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AKRO
Akero Therapeutics Inc
|
44.91 | 3.36B | 0 | -237.22M | -212.64M | -3.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.73 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.24 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.39 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
269.31 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.48 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Akero Therapeutics Inc Stock (AKRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-30 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-01-27 | 재확인 | H.C. Wainwright | Buy |
| 2024-11-18 | 개시 | Citigroup | Buy |
| 2024-04-22 | 재개 | BofA Securities | Neutral |
| 2023-09-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-08-28 | 개시 | UBS | Buy |
| 2023-01-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-10-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-10 | 개시 | BofA Securities | Buy |
| 2021-02-26 | 개시 | Guggenheim | Buy |
| 2020-09-10 | 개시 | Morgan Stanley | Overweight |
| 2020-07-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-07 | 개시 | Chardan Capital Markets | Buy |
| 2020-07-01 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-02 | 개시 | H.C. Wainwright | Buy |
| 2020-02-10 | 개시 | Canaccord Genuity | Buy |
| 2019-07-15 | 개시 | Evercore ISI | Outperform |
| 2019-07-15 | 개시 | JP Morgan | Overweight |
| 2019-07-15 | 개시 | Jefferies | Buy |
| 2019-07-15 | 개시 | ROTH Capital | Buy |
모두보기
Akero Therapeutics Inc 주식(AKRO)의 최신 뉴스
Long-Term Shareholders Have Rights – If You Hold Akero Therapeutics, Inc. (NASDAQ: AKRO); ... - Bluefield Daily Telegraph
Long-Term Shareholders Have Rights – If You Hold Akero Therapeutics, Inc. (NASDAQ: AKRO); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); or Virtu Financial Inc. (NASDAQ: VIRT), Contact Grabar La - TradingView
Alkeon Capital Management LLC Sells 1,563,736 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
5AM Venture Management LLC Takes Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Renaissance Technologies LLC Invests $579,000 in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Sold by Schonfeld Strategic Advisors LLC - MarketBeat
Aquatic Capital Management LLC Buys 14,841 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Invesco Ltd. Purchases 21,086 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics (AKRO) Expected to Announce Quarterly Earnings on Friday - MarketBeat
T. Rowe Price Investment Management Inc. Decreases Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Foresite Capital Management VI LLC Makes New $10.15 Million Investment in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $256,437.50 in Stock - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Purchased by Price T Rowe Associates Inc. MD - MarketBeat
Brokerages Set Akero Therapeutics, Inc. (NASDAQ:AKRO) Target Price at $76.29 - Defense World
Tower Research Capital LLC TRC Has $450,000 Stake in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics (AKRO) Projected to Post Quarterly Earnings on Friday - Defense World
Analysts Set Akero Therapeutics, Inc. (NASDAQ:AKRO) Target Price at $76.29 - MarketBeat
Dark Forest Capital Management LP Buys Shares of 16,893 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Wells Fargo & Company MN Acquires 7,587 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
How does Akero Therapeutics Inc (AKRO) change from a tortoise to a hare? - Sete News
AKRO’s 2023 Market Dance: Up 63.95% – Time to Invest? - investchronicle.com
Emerald Mutual Fund Advisers Trust Lowers Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics (AKRO) Receives Buy Rating with Promising Pot - GuruFocus
Akero Therapeutics Inc (AKRO) receives a Buy rating from BofA Securities - knoxdaily.com
Jump Financial LLC Decreases Stake in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero (AKRO) Among Leading FGF21 Developers, Says Cantor Fitzgerald | AKRO Stock News - GuruFocus
Do investors need to be concerned about Akero Therapeutics Inc (AKRO)? - uspostnews.com
Akero Therapeutics Announces Upcoming Poster And Oral Presentations At The Easl Congress 2025 - marketscreener.com
Akero Therapeutics Announces Upcoming Poster and Oral Presentations at the EASL Congress 2025 - GlobeNewswire
Breakthrough: Akero's Efruxifermin Demonstrates Fibrosis Improvement in 96-Week MASH Trial - Stock Titan
(AKRO) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Quarterly Metrics: Quick and Current Ratios for Akero Therapeutics Inc (AKRO) - DWinneX
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Purchased by Barclays PLC - American Banking and Market News
Akero Therapeutics, Inc. (NASDAQ:AKRO) Position Increased by Invesco Ltd. - Defense World
Marshall Wace LLP Invests $7.65 Million in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Investor’s Delight: Akero Therapeutics Inc (AKRO) Closes Weak at 38.64, Down -4.55 - DWinneX
Akero Therapeutics, Inc. (NASDAQ:AKRO) Position Boosted by Wells Fargo & Company MN - Defense World
260,000 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Acquired by B Group Inc. - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock Holdings Lifted by Rock Springs Capital Management LP - MarketBeat
Akero Therapeutics Inc [AKRO] stock for 343,962 USD was sold by Yale Catriona - knoxdaily.com
AMRX Stock Sees Surge of Approximately 3.34% in Last Five Days - knoxdaily.com
Insider’s View: Deciphering Akero Therapeutics Inc (AKRO)’s Financial Health Through Ratios - DWinneX
Akero Therapeutics Inc (AKRO) looking to reclaim success with recent performance - Sete News
Akero Therapeutics Inc (AKRO) shows promising results - uspostnews.com
Walleye Capital LLC Takes $3.75 Million Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Akero Therapeutics, Inc. to - Bluefield Daily Telegraph
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Akero Therapeutics, Inc. to Contact Law Firm - TradingView
Akero Therapeutics Inc (AKRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
0.30%
자본화:
|
볼륨(24시간):